Exenatide for Treating Cocaine Use Disorder
NCT04941521
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Cocaine Use Disorder
Interventions
DRUG:
Exenatide 2 mg [Bydureon]
BEHAVIORAL:
Drug Counseling
Sponsor
The University of Texas Health Science Center, Houston